Home › Funds › Alpine Peaks Capital, LP › WST
Alpine Peaks Capital, LP position in WST
WEST PHARMACEUTICAL SVSC INC · Health Care
Alpine Peaks Capital, LP reported holding 16,691 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$6.2M, representing 7.95% of its reported portfolio and ranking #2 among its reported holdings. Alpine Peaks Capital, LP has disclosed WST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Alpine Peaks Capital, LP's WST position evolved
Alpine Peaks Capital, LP first disclosed a stake in WST in Q3 2023 at 20,827 shares (US$7.8M). The position peaked in Q1 2024 at 20,827 shares, worth US$8.2M. Across 13 filings, Alpine Peaks Capital, LP increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 16,691 shares valued at US$6.2M — a reduction of -2,500 shares quarter over quarter.. Notable position changes include a 36% trim in Q2 2026 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 20.83K | $7.81M | New |
| Q4 2023 | 20.83K | $7.33M | Hold |
| Q1 2024 | 20.83K | $8.24M | Hold |
| Q2 2024 | 20.83K | $6.86M | Hold |
| Q3 2024 | 23.50K | $7.05M | Add |
| Q4 2024 | 19.73K | $6.46M | Reduce |
| Q1 2025 | 21.23K | $4.75M | Add |
| Q2 2025 | 21.83K | $4.78M | Add |
| Q3 2025 | 26.83K | $7.04M | Add |
| Q4 2025 | 26.48K | $7.29M | Reduce |
| Q1 2026 | 29.88K | $7.49M | Add |
| Q2 2026 | 19.19K | $6.89M | Reduce |
| Q3 2026 | 16.69K | $6.19M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About WST and 13F data
WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 28 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$744.4M), BROWN ADVISORY INC (US$346.9M), Longview Partners (Guernsey) LTD (US$343.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding WST
- Artisan Partners Limited Partnership 2.01M sh · $744.42M · Q3 2026
- BROWN ADVISORY INC 935.74K sh · $346.94M · Q3 2026
- Longview Partners (Guernsey) LTD 927.47K sh · $343.87M · Q3 2026
- GENERATION INVESTMENT MANAGEMENT LLP 835.99K sh · $309.95M · Q3 2026
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 687.78K sh · $255.00M · Q3 2026
More on Alpine Peaks Capital, LP
FAQ
How long has Alpine Peaks Capital, LP held WST?
Alpine Peaks Capital, LP has disclosed WST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Alpine Peaks Capital, LP's current position in WST?
As of Q3 2026, Alpine Peaks Capital, LP holds 16.69K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $6.19M, representing 7.95% of its reported portfolio and ranking #2.
Has Alpine Peaks Capital, LP been buying or selling WST?
In the latest 13F filing (Q3 2026), Alpine Peaks Capital, LP reduced its position in WST. The position peaked in Q1 2024 at 20.83K shares.
Which other funds hold WST?
Other major institutional holders of WST include Artisan Partners Limited Partnership, BROWN ADVISORY INC, Longview Partners (Guernsey) LTD, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.